LONDON - The survival rate for men with aggressive prostate cancer could improve after it was found that adding a hormone therapy to their treatment halved deaths.
The results of a trial of Abiraterone are expected to change the standard of care worldwide, experts said.
Meanwhile, The Telegraph reported that scientists believe men could be cured of prostate cancer in a week using larger doses of precision radiotherapy.